Physician profile
Chen Xie
NPI 1659467843
$3,377.13
in general payments reported to CMS, 2019-2025
14 companies · $1,585 in 2025
The $1,585 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.01 · 2020: $12.93 · 2021: $36.55 · 2022: $257 · 2023: $853 · 2024: $575 · 2025: $1,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,013.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,246.04 | 2023-2025 | Inspire |
| Genzyme Corporation | $469.88 | 2022-2025 | |
| Glaxosmithkline, LLC. | $419.24 | 2021-2025 | Nucala |
| Optinose US, INC. | $398.67 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $251.81 | 2022-2025 | Dupixent |
| Olympus America INC. | $122.10 | 2022-2023 | Diego Elite |
| Aerin Medical INC. | $119.65 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $109.39 | 2025 | |
| Medtronic, INC. | $77.27 | 2023-2025 | Stealthstation S8 Platform, Propel |
| Integra Lifesciences Corporation | $61.00 | 2024-2025 | Acclarent Aera, Inspira Air, Relieva Spinplus Nav |
| Stryker Corporation | $30.75 | 2019-2020 | |
| Pharming Healthcare, INC. | $25.83 | 2025 | Ruconest |
| Karl Storz Endoscopy-America | $24.61 | 2022 | |
| Ambu INC. | $20.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chen Xie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.